SE0403172D0 - Manufacturing process - Google Patents

Manufacturing process

Info

Publication number
SE0403172D0
SE0403172D0 SE0403172A SE0403172A SE0403172D0 SE 0403172 D0 SE0403172 D0 SE 0403172D0 SE 0403172 A SE0403172 A SE 0403172A SE 0403172 A SE0403172 A SE 0403172A SE 0403172 D0 SE0403172 D0 SE 0403172D0
Authority
SE
Sweden
Prior art keywords
manufacturing process
manufacturing
tetrahydropyridazino
dione
quinoline
Prior art date
Application number
SE0403172A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0403172A priority Critical patent/SE0403172D0/sv
Publication of SE0403172D0 publication Critical patent/SE0403172D0/sv
Priority to PCT/SE2005/002019 priority patent/WO2006068617A1/en

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0403172A 2004-12-23 2004-12-23 Manufacturing process SE0403172D0 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0403172A SE0403172D0 (sv) 2004-12-23 2004-12-23 Manufacturing process
PCT/SE2005/002019 WO2006068617A1 (en) 2004-12-23 2005-12-22 A new manufacturing process for the preparation of halogen substituted 4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0403172A SE0403172D0 (sv) 2004-12-23 2004-12-23 Manufacturing process

Publications (1)

Publication Number Publication Date
SE0403172D0 true SE0403172D0 (sv) 2004-12-23

Family

ID=34102120

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0403172A SE0403172D0 (sv) 2004-12-23 2004-12-23 Manufacturing process

Country Status (2)

Country Link
SE (1) SE0403172D0 (sv)
WO (1) WO2006068617A1 (sv)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003519146A (ja) * 1999-12-23 2003-06-17 アストラゼネカ・アクチエボラーグ 痛みの処置のための方法および組成物
ATE294177T1 (de) * 1999-12-23 2005-05-15 Astrazeneca Ab Pyridazino-quinolin derivat und verfahren zur behandlung von schmerz
AU2420101A (en) * 1999-12-23 2001-07-09 Astrazeneca Ab Method and composition for the treatment of pain
EP1248621A1 (en) * 1999-12-23 2002-10-16 AstraZeneca AB Method and composition for the treatment of pain
US20050124622A1 (en) * 1999-12-23 2005-06-09 Brown Dean G. Compounds and methods for the treatment of pain
JP2003519145A (ja) * 1999-12-23 2003-06-17 アストラゼネカ・アクチエボラーグ 痛みの処置のための化合物および方法

Also Published As

Publication number Publication date
WO2006068617A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
BRPI0519302A2 (pt) etanossulfonato de sais de 1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amin o e metanossulfonato de 1-(2-metilpropil)-1h-imidazo[4,5-c][1,5]naftiridin-4-amin a, composiÇÕes contendo os mesmos, processos de preparaÇço e uso
WO2006086633A3 (en) Substituted fused [1,2]imidazo[4,5-c] ring compounds and methods
WO2001066534A3 (en) Cyclic and bicyclic diamino histamine-3 receptor antagonists
WO2007106852A3 (en) Substituted fused[1,2]imidazo[4,5-c] ring compounds and methods
PE20141557A1 (es) Derivado de pirazoloquinolina
PE20070002A1 (es) Compuestos derivados de heteroaril como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo i
BR0309463A (pt) Derivados de 1,2,3,4,7,8-hexaidro-6h-[1,4]diazepino[6,7,1-ij]quinolina como agentes antipsicóticos e antiobesidade
WO2006074003A3 (en) CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
ECSP055807A (es) Quinolinilpirrolopirazoles
MX2007005478A (es) Formulaciones de derivados de [1,4]diazepino[6,7,1-ij]quinolina.
NO20054208L (no) Nitrogen-substituerte heksahydropyrazino[1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
MY137609A (en) Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
NO20081365L (no) Ny krystallinsk form av et pyridazino[4,5-b]indolderivat
GEP20094720B (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
WO2006066950A3 (de) Tricyclische aminoalkohole, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE486602T1 (de) Pyrrolo (3, 2, 1-ij) chinolin-4-on-derivate zur behandlung von tuberkulose
HRP20120918T1 (hr) Aminopirazolski spoj
NO20080033L (no) Kinolinderivater som NK3-antagonister
DE602005021150D1 (de) 3-substituierte pyridinderivate als h3-antagonisten
CY1111227T1 (el) Mεθοδος παρασκευης 1-υποκατασταθεισων ενωσεων 1η-ιμιδαζο[4,5-c]κινολιν-4-αμινης και ενδιαμεσα γι' αυτην.
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
DE602005017145D1 (de) Verwendung von opioid-rezeptorantagonisten zur prävention und/oder behandlung von erkrankungen im zusammenhang mit dem target calcineurin
MA28179A1 (fr) Nouveau compose, compositions correspondantes, methodes de fabrication et/ou de traitement
ATE512968T1 (de) 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
EA200601176A1 (ru) 3-цианохинолиновые производные с антипролиферативной активностью